Quest Diagnostics (DGX) Tops Q2 Earnings, Raises 2024 Outlook
U.S. Apheresis Equipment (Disposable Kits, Device, Renal Disease, Neurology) Market Size, Share & Trends Analysis Report 2024-2030 - ResearchAndMarkets.com
Haemonetics' (NYSE:HAE) 14% CAGR Outpaced the Company's Earnings Growth Over the Same Three-year Period
Haemonetics (HAE) Banks on Growing Hospital Arm, New Launches
Thermo Fisher (TMO) Inks New Partnership for MyeloMATCH Trial
Does Haemonetics (NYSE:HAE) Have A Healthy Balance Sheet?
Top Medical Stocks to Buy for Growth & Performance
Wall Street Analysts Think Haemonetics (HAE) Could Surge 33.2%: Read This Before Placing a Bet
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024
Haemonetics Launches New Vascade MVP XL Mid-bore Venous Closure Device
Haemonetics (HAE) Expands VASCADE Line With New Limited Launch
Haemonetics Launches VASCADE MVP XL Device for Venous Closure
Express News | Haemonetics Announces A Limited Market Release Of Its VASCADE MVP XL Vascular Closure Device
Express News | Haemonetics Launches Limited Market Release for New Vascade Mvp Xl Vascular Closure Device
Haemonetics Corporation's (NYSE:HAE) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Haemonetics (HAE) Is a Top-Ranked Value Stock: Should You Buy?
Zacks.com Featured Highlights Include Skechers, Walmart, Haemonetics, AZZ and BOK Financial
Haemonetics (HAE) Banks on Growing Plasma Arm, Innovation
DaVita (DVA) Gains 36% YTD: What's Driving the Stock Rally?
Buy 5 Stocks With Upgraded Broker Ratings for Robust Returns